SCHEMBL30296233

SCHEMBL30296233

CC(=O)Nc1cc(Cl)ccc1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.59
HSD17B10 Q99714 1/20 0.59
EPHX1 P07099 1/20 0.50
GRIK1 P39086 1/20 0.49
KMT2A Q03164 3/20 0.48
HDAC1 Q13547 2/20 0.48
HDAC6 Q9UBN7 1/20 0.47
ADORA2A P29274 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
TMPRSS4 Q9NRS4 1/20 0.47
KCNMA1 Q12791 3/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
MEN1 O00255 1/20 0.46
POLB P06746 1/20 0.46
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
TAS1R2 Q8TE23 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9403860 1.00 KDM4E (0.59) KDM4EHSD17B10EPHX1GRIK1KMT2A
SCHEMBL29683063 0.87 KDM4E (0.62) KDM4EHSD17B10KMT2AHDAC1HDAC6
SCHEMBL3873599 0.87 KDM4E (0.62) KDM4EHSD17B10KMT2AHDAC1HDAC6
SCHEMBL3782005 0.84 KDM4E (0.68) KDM4EHSD17B10EPHX1KMT2AHDAC1
SCHEMBL29177448 0.82 GRIK1 (0.54) KDM4EGRIK1KMT2ANPC1RAB9A
SCHEMBL29791333 0.82 GRIK1 (0.54) KDM4EGRIK1KMT2ANPC1RAB9A
SCHEMBL8955980 0.82 SMN1; SMN2 (0.55) KDM4EKMT2AHDAC1HDAC6CA1
SCHEMBL30748254 0.82 SMN1; SMN2 (0.55) KDM4EKMT2AHDAC1HDAC6CA1
SCHEMBL20560214 0.82 GRIK1 (0.50) GRIK1KMT2ANPC1RAB9ATMPRSS4
SCHEMBL2388970 0.82 EPHX1 (0.70) KDM4EHSD17B10EPHX1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4702021-A1 COMPOUNDS CAPABLE OF MODULATING GPR65 Pathios Therapeutics Limited (GB) 2026-03-04 EP disclosed
WO-2024224064-A1 COMPOUNDS CAPABLE OF MODULATING GPR65 Pathios Therapeutics Limited (GB) 2024-10-31 WO disclosed
EP-4419203-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2024-08-28 EP disclosed
CN-118451080-A Tricyclic GPR65 modulators 帕蒂奥斯治疗有限公司 2024-08-06 CN disclosed
WO-2023067322-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2023-04-27 WO disclosed